Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women.

Status Withdrawn

Clinical Trial Summary

Menopause is a physiological event and is defined as the loss of ovarian follicular activity, with consequent permanent cessation of menstrual cycles. Its diagnosis is made retrospectively after 12 months of amenorrhea, with no pathological cause involved. This period is marked by several changes in the female organism, mainly the genitourinary syndrome (GUS), which is a collection of signs and symptoms resulting from the state of hypoestrogenism. Almost half of postmenopausal women will experience symptoms of GUS, with vaginal dryness being the most prevalent, followed by dyspareunia and vulvovaginal irritation. The aim of the study is to evaluate the effect of photobiomodulation with red LED (ligth emitting diode) on the symptoms of vulvovaginal atrophy in postmenopausal women. A randomized and controlled clinical trial will be developed, which will include postmenopausal women with signs and symptoms of vulvovaginal atrophy. Participants will be allocated into two groups: those who will undergo photobiomodulation with intravaginal LED, and those who will receive vaginal cream with estriol. Objective and subjective improvement of atrophy will be assessed using the Vaginal Health Index and the visual analog scale, respectively. Vaginal pH, cell maturation index and changes in sexual function through the Female Sexual Function Index questionnaire will also be assessed. The variables will be analyzed at the time of admission, in one and three months after the intervention.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04487392
Study type	Interventional
Source	University of Nove de Julho
Contact
Status	Withdrawn
Phase	Phase 2
Start date	December 15, 2020
Completion date	December 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04210583` - RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity	N/A
Completed	`NCT03725410` - Multi-polar RF and PEMF for Treatment of Symptoms Associated With Vulvovaginal Atrophy	N/A
Recruiting	`NCT03823560` - Performance and Safety of Class IIb MD Celegyn® in VVA	N/A
Completed	`NCT02253173` - Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women	Phase 3
Withdrawn	`NCT03666819` - Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy	Phase 2
Recruiting	`NCT04746456` - Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROM
Completed	`NCT04607798` - Multi-polar RF and PEMF for Treatment of Vulvovaginal Atrophy	N/A
Completed	`NCT04766957` - Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy	N/A
Completed	`NCT01455597` - Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)	Phase 3
Completed	`NCT03557398` - Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause Women	N/A
Completed	`NCT03044652` - Investigation of Non-inferiority of Treatment of Vulvovaginal Dryness With WO2085 Moisturising Cream in Comparison to a Cream With 0.1% Estriol	Phase 4
Completed	`NCT03536585` - Multi-polar RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity	N/A
Completed	`NCT04629885` - Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms	Phase 2
Recruiting	`NCT04579991` - Effects of Visnadin, Ethyl Ximeninate, Coleus Barbatus and Millet in Emulgel on Sexual Function in Postmenopausal Women	N/A
Recruiting	`NCT05562518` - GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.	Phase 4
Completed	`NCT02419729` - Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy	Phase 3
Completed	`NCT02085980` - Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy	N/A
Completed	`NCT01319968` - Postpartum Dyspareunia Resulting From Vaginal Atrophy	N/A
Recruiting	`NCT03782480` - Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy	Phase 3
Completed	`NCT04887701` - Non-hormonal Medical Device for Treatment of Vulvovaginal Atrophy (VVA) in Post-Menopausal Women	N/A